Prescription required after clinical evaluation
We chose a fixed-effects model when heterogeneity was low
However, for people with significant metabolic dysfunction like type 2 diabetes, the enhanced metabolic benefits might matter
Kleinert M, Sachs S, Habegger KM, Hofmann SM, Mller TD (2019) Glucagon regulation of energy expenditure
d , Time-series confocal microscopy analysis of SNAP/FLAG-hGLP-1R (red) and EGFP-VAPB (green) localisation in response to exendin-4 (Ex-4) in INS-1 832/3 SNAP/FLAG-GLP-1R cells
Baseline assessment and initial monitoring Metabolic deterioration associated with insulin resistance, including obesity, hyperlipidemia, and a history of hyperglycemia, should be assessed, as these factors predispose individuals to the development of GIH [9]